Monitoring Agency Report

Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com; co.sec@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Date: October 08, 2026 Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block BSE Scrip Code: 544339 Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: LAXMIDENTL Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020 Dear Sir(s)/Madam(s), Subject: Report of Monitoring Agency for the quarter ended September 30, 2026. Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed herewith Monitoring Agency Report issued by ICRA Limited, the Monitoring Agency, for the quarter ended September 30, 2026, in respect of the utilization of the proceeds of the Initial Public Offer (“IPO”) of the Company. The same is also being uploaded on website of the Company at https://laxmidentallimited.com/for- investors#disclosures--disclosures30. This is for your information and records. Thanking you, For Laxmi Dental Limited Suman Saha Company Secretary and Compliance Officer ICSI Membership Number: A33035 Encl.: As above. September2026 MONITORING AGENCYREPORT Name of the Issuer:Laxmi Dental Limited For quarter ended:September30,2026 Name of the Monitoring Agency(MA):ICRA Limited (a) Deviation from the objects of the issue: NoMaterial deviation -The utilization of the issuance proceeds is in line with the objects of the issue. (b) Range of deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit relatedanalyses. We confirm that we do not perceive any conflict of interest in such relationship/ interest while monitoring and reporting the utilization of the issue proceeds by the issuer. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no Signature: ParulGoyalNarang Vice President & Head-Process Excellence Analyst: Dhwani Vinchhi QA: Parul Narang Sensitivity Label : Public September2026 1. IssuerDetails Name of the Issuer: Laxmi Dental Limited Name(s) of the promoters: Promoters Rajesh Vrajlal Khakhar Sameer Kamlesh Merchant Dharmesh Bhupendra Dattani Source: BSE Industry/ sector to which it belongs:Health Care sector 2. Issue Details Issue Period:Openingdate-January13, 2025 Closingdate-January15, 2025 Type of Issue:Initial Public Offer Type of specified securities:Equityshares IPO Grading, if any: Not Applicable Issue Size (Rs. Crore):Issue of16,309,766 equity shares of face value of INR2each,aggregatingupto INR698.058 Crore With OFS portion:INR698.058Crore Excluding OFS portion:INR 138.000Crore Net proceedsas per prospectus: INR 128.170Crore Note:ICRA will be monitoring GrossProceedsINR138.000Crorein Q2FY2027 Sensitivity Label : Public September2026 3. Details of the arrangement made to ensure the monitoring of issue proceeds. Source of information, Comments of Comments of the certifications considered by the Particulars Reply Monitoring Monitoring Agency for the Board of Agency preparation of report Directors Refer note 1 mentioned below point no 4 (ii) -Peer-reviewed CAcertificate progress on objects and -Confirmation from management Whether all utilization is as per Approval of -Bank statement of the escrow the disclosures in the Offer Yes shareholders for account/Proceed Document? change in Account/Corresponding Account deployment of bank statements funds has been obtained in the 22ndAGM held on 25thSep2026 Approval of Whether shareholder approval shareholders for change in has been obtained in case of deployment of material deviations#from Yes management funds has been expenditures disclosed in the obtained in the Offer Document? 22ndAGM held on 25thSep2026 Whether the means of finance As confirmed by the for the disclosed objects of the No No comments management issue has changed? Is there any major deviation observed over the earlier No No deviation observed No comments monitoring agency reports? Whether all Government/ As understood statutory approvals related to Not the object(s) have been Applicable management management obtained? Whether all arrangements As understood pertaining to technical Not assistance/ collaboration are in Applicable management management operation? Are there any favorable events As understood improving the viability of these Applicable management object(s)? management Sensitivity Label : Public September2026 Source of information, Comments of Comments of the certifications considered by the Particulars Reply Monitoring Monitoring Agency for the Board of Agency preparation of report Directors Are there any unfavorable As understood events affecting the viability of No management the object(s)? management Is there any other relevant As understood information that may materially affect the decision making of the management management investors? #Where material deviation is defined to mean: (a) Deviation in the objects or purposes for which the funds had been raised. (b) Deviation in the amount of funds utilizedby more than 10% of the amount specified in the offer document. Sensitivity Label : Public September2026 4. Details of the object(s) to be monitored. (i)Cost of object(s) Source of information, Directors Original certifications Comments cost (as per Revised considered by of the Particulars S.N. Item Head the offer cost Reason Proposed the Monitoring Monitoring of firm document) [Rs. Crore] for cost financing Agency for the Agency arrangemen [Rs. Crore] revision option preparation of ts made report Repayment/prepaym ent, in full or in part, of certain Not No 1 outstanding Prospectus 22.984 Applicable comments borrowings availed by our Company Investment in certain Subsidiaries for the repayment/prepaym ent, in full or in part, Not No 2 Prospectus 4.600 of certain Applicable comments outstanding borrowings Prospectus/ Intimation of Funding the capital 22nd Annual expenditure General requirements for Meeting No 3 purchase of new 43.507 17.781 comments machinery for our scheduled to be Company held on, September 25, 2 [Showing first 8,000 characters — download PDF for full document]